Adagene (ADAG) Notes Payables (2019 - 2025)
Adagene's (ADAG) quarterly Notes Payables came in at $4268.2 billion in Q4 2025, down 12.34% year-on-year from $4869.0 billion in Q4 2024, and up 203693259.97% on a QoQ basis from $2.1 million in Q2 2025.
Adagene (ADAG) Notes Payables (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Notes Payables data on file, last reported at $4268.2 billion in Q4 2025.
- On a quarterly basis, Notes Payables fell 12.34% year-over-year to $4268.2 billion in Q4 2025; TTM through Dec 2025 was $4268.2 billion, a 12.34% decrease from a year earlier, with the FY2025 full-year figure at $4268.2 billion, down 12.34% from the prior year.
- Notes Payables for Q4 2025 stood at $4268.2 billion, up from $2.1 million in the prior quarter.
- Over the last five years, Notes Payables for ADAG reached as high as $10768.7 billion in Q4 2022 and fell as low as $2.1 million in Q2 2025.
- Historically, Notes Payables has averaged $3909.7 billion across 5 years, with a median of $4251.9 billion in 2023.
- Across the five-year window, Notes Payables soared 345016409.54% in 2022 and slumped 100.0% in 2024, its largest moves.
- Year by year, Notes Payables stood at $3.1 million in 2021, then surged by 345016409.54% to $10768.7 billion in 2022, then slumped by 60.67% to $4235.7 billion in 2023, then gained by 14.95% to $4869.0 billion in 2024, then retreated by 12.34% to $4268.2 billion in 2025.
- Per Business Quant data, the three most recent Notes Payables figures were $4268.2 billion in Q4 2025, $2.1 million in Q2 2025, and $4869.0 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,268.15 Bn |
| Jun 30, 2025 | 2.10 Mn |
| Dec 31, 2024 | 4,868.96 Bn |
| Jun 30, 2024 | 4.21 Mn |
| Dec 31, 2023 | 4,235.67 Bn |
| Jun 30, 2023 | 8,995.54 Bn |
| Dec 31, 2022 | 10,768.75 Bn |
| Jun 30, 2022 | 5,960.01 Bn |
| Dec 31, 2021 | 3.12 Mn |
| Jun 30, 2021 | 3.85 Mn |
| Dec 31, 2020 | 3.83 Mn |
| Dec 31, 2019 | 716,723.00 |